IceCure Medical Statistics

Total Valuation

IceCure Medical has a market cap or net worth of $61.84 million. The enterprise value is $56.18 million.

Market Cap	61.84M
Enterprise Value	56.18M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025, before market open.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

IceCure Medical has 58.62 million shares outstanding. The number of shares has increased by 16.74% in one year.

Current Share Class	58.62M
Shares Outstanding	58.62M
Shares Change (YoY)	+16.74%
Shares Change (QoQ)	+2.92%
Owned by Insiders (%)	47.55%
Owned by Institutions (%)	0.22%
Float	30.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.28
Forward PS	n/a
PB Ratio	10.31
P/TBV Ratio	10.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	17.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.06.

Current Ratio	1.89
Quick Ratio	1.27
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -173.47% and return on invested capital (ROIC) is -105.73%.

Return on Equity (ROE)	-173.47%
Return on Assets (ROA)	-72.28%
Return on Invested Capital (ROIC)	-105.73%
Return on Capital Employed (ROCE)	-257.09%
Revenue Per Employee	$49,591
Profits Per Employee	-$231,773
Employee Count	66
Asset Turnover	0.24
Inventory Turnover	0.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.32% in the last 52 weeks. The beta is 2.51, so IceCure Medical's price volatility has been higher than the market average.

Beta (5Y)	2.51
52-Week Price Change	+42.32%
50-Day Moving Average	1.05
200-Day Moving Average	1.02
Relative Strength Index (RSI)	56.77
Average Volume (20 Days)	321,165

Short Selling Information

The latest short interest is 206,073, so 0.35% of the outstanding shares have been sold short.

Short Interest	206,073
Short Previous Month	213,846
Short % of Shares Out	0.35%
Short % of Float	0.67%
Short Ratio (days to cover)	0.93

Income Statement

In the last 12 months, IceCure Medical had revenue of $3.27 million and -$15.30 million in losses. Loss per share was -$0.29.

Revenue	3.27M
Gross Profit	1.40M
Operating Income	-15.70M
Pretax Income	-14.49M
Net Income	-15.30M
EBITDA	-15.37M
EBIT	-15.70M
Loss Per Share	-$0.29

Full Income Statement

Balance Sheet

The company has $6.04 million in cash and $380,000 in debt, giving a net cash position of $5.66 million or $0.10 per share.

Cash & Cash Equivalents	6.04M
Total Debt	380,000
Net Cash	5.66M
Net Cash Per Share	$0.10
Equity (Book Value)	6.00M
Book Value Per Share	0.10
Working Capital	4.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.75 million and capital expenditures -$49,000, giving a free cash flow of -$13.80 million.

Operating Cash Flow	-13.75M
Capital Expenditures	-49,000
Free Cash Flow	-13.80M
FCF Per Share	-$0.24

Full Cash Flow Statement

Margins

Gross Margin	42.77%
Operating Margin	-479.77%
Pretax Margin	-467.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IceCure Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.74%
Shareholder Yield	n/a
Earnings Yield	-24.74%
FCF Yield	-22.31%

Analyst Forecast

The average price target for IceCure Medical is $2.50, which is 136.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.50
Price Target Difference	136.97%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	93.21%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IceCure Medical has an Altman Z-Score of -11.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.93
Piotroski F-Score	3